Looking for an exciting opportunity to build and lead a sales team in Italy, and become a part of DNA testing industry? GenePlanet, EU based biotech company, a global leader in the field of preventive genetic
Job Title: Medical Director, Oncology Location: Rome, Italy (Home based – any Italy location considered) Shape the future of oncology drug development Caidya, a mid-sized global CRO, is seeking a Medical Director with experience in oncology
Key Account Manager - Italy (Hematology/Oncology) Job type: Contract · Department: Provider Engagement · Work type: Remote Italy; Palermo, Sicily, Italy; Metropolitan City of Rome Capital, Lazio, Italy; Metropolitan City of Turin, Piedmont, Italy; Metropolitan City
This is not a classic product manager role. Youll work with technology that oncologists actually get excited about. Minimally invasive. Evidence-backed. Still underused. That gap is your opportunity. Your job is not to sell. Its to make
Looking for an exciting opportunity to build and lead a sales team in Italy, and become a part of DNA testing industry? GenePlanet , EU based biotech company, a global leader in the field of preventive
Job Title : Medical Director, Oncology Location : Rome, Italy (Home based – any Italy location considered) Shape the future of oncology drug development Caidya, a mid-sized global CRO, is seeking a Medical Director with experience
Key Account Manager – Italy (Hematology/Oncology) – Torino Massive Bio Torino, Salary: EUR 50,000 - 70,000. About Massive Bio Every cancer patient deserves access to treatment options. Massive Bio is an AI‑powered precision medicine platform transforming
Nucs-AI is seeking a Clinical Operations Manager to oversee clinical study management and coordination. You will be pivotal in executing clinical validation studies and ensuring compliance with protocols while working with top oncologists and AI researchers. The
A leading healthcare company is seeking a Key Account Manager based in Italy to expand its physician network and enhance patient referrals for clinical trials. The ideal candidate will have over 4 years of relevant experience,
About Massive Bio Every cancer patient deserves access to treatment options. Massive Bio is an AI‑powered precision medicine platform transforming how cancer patients discover and access clinical trials by eliminating the barriers of geography, financial constraints,
Nucs-AI is seeking a Clinical Operations Manager to oversee clinical study management and coordination. You will be pivotal in executing clinical validation studies and ensuring compliance with protocols while working with top oncologists and AI researchers. The
This is not a classic product manager role. Pronto/a a candidarsi? Prima di farlo, si assicuri di leggere tutti i dettagli relativi a questo lavoro nella descrizione sottostante. You’ll work with technology that oncologists actually get excited
This is not a classic product manager role. Youll work with technology that oncologists actually get excited about. Minimally invasive. Evidence-backed. Still underused. That gap is your opportunity. Your job is not to sell. Its to make
This is not a classic product manager role.Per una comprensione completa di questa opportunità e dei requisiti per essere un candidato di successo, continui a leggere.Youll work with technology that oncologists actually get excited about.Minimally invasive. Evidence-backed.
About Nucs AI Nucs AI is revolutionizing prostate cancer care through cutting‑edge AI and medical imaging technology. Founded in 2024 by a multidisciplinary team of oncologists, AI researchers, and healthcare innovators, were tackling one of medicines most
Experteer Overview As Medical Director in oncology, you oversee medical monitoring across global trials and support delivery of innovative cancer therapies. You will ensure patient safety, data integrity, and regulatory compliance while collaborating with sponsors and
Senior/Executive Medical Director, Clinical Development, Solid Tumors Responsibilities The Senior/Executive Medical Director, Clinical Development, Solid Tumors will be responsible for driving the global clinical development strategy in solid tumors, specifically Stemline’s Breast Cancer product, Elecestrant. The